Table 1 Patient characteristics (n = 80 patients).

From: Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients

N. patients (%)

80 (100%)

Gender

Male

32 (40%)

Female

48 (60%)

Median age (range)

60 (39–89)

Histological subtype

Squamous

80 (100%)

Localization

Anal canal

56 (70%)

Anal canal + rectal

12 (15%)

Anal canal + margin

12 (15%)

T1

14 (18%)

T2

30 (37%)

T3

24 (30%)

T4*

12 (15%)*

 

*8: vagina

1: uterus

3: prostate

N0

29 (36%)

N1

17 (21%)

N2

14 (18%)

N3

20 (25%)

M0

73 (91%)

M1*

7 (9%)*

 

*3: external iliac

2: liver (1: liver + bone)

2: retroperitoneal

HIV status

Positive

27 (34%)

F: 6 (22%); M: 21 (78%)

Negative

53 (66%)

F: 42 (79%); M: 11 (21%)